C-Abl Inhibits Breast Cancer Tumorigenesis Through Reactivation of P53-Mediated P21 Expression
Oncotarget - United States
doi 10.18632/oncotarget.11909
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 8, 2016
Authors
Publisher
Impact Journals, LLC